These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 37626387)

  • 1. Evaluating the effect of prebiotics on the gut microbiome profile and β cell function in youth with newly diagnosed type 1 diabetes: protocol of a pilot randomized controlled trial.
    Ismail HM; Spall M; Evans-Molina C; DiMeglio LA
    Pilot Feasibility Stud; 2023 Aug; 9(1):150. PubMed ID: 37626387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and effects of acetylated and butyrylated high amylose maize starch in recently diagnosed youths with type 1 diabetes; a Pilot Study.
    Ismail HM; Liu J; Netherland M; Evans-Molina C; DiMeglio LA
    medRxiv; 2024 Jun; ():. PubMed ID: 38798462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation.
    Bell KJ; Saad S; Tillett BJ; McGuire HM; Bordbar S; Yap YA; Nguyen LT; Wilkins MR; Corley S; Brodie S; Duong S; Wright CJ; Twigg S; de St Groth BF; Harrison LC; Mackay CR; Gurzov EN; Hamilton-Williams EE; Mariño E
    Microbiome; 2022 Jan; 10(1):9. PubMed ID: 35045871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Starch acylation of different short-chain fatty acids and its corresponding influence on gut microbiome and diabetic indexes.
    Li M; Wang F; Wang J; Wang A; Yao X; Strappe P; Zhou Z; Wu Q; Guo T
    Food Chem; 2022 Sep; 389():133089. PubMed ID: 35490527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistant Starch is Actively Fermented by Infant Faecal Microbiota and Increases Microbial Diversity.
    Gopalsamy G; Mortimer E; Greenfield P; Bird AR; Young GP; Christophersen CT
    Nutrients; 2019 Jun; 11(6):. PubMed ID: 31208010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-Chain Fatty Acid Production by Gut Microbiota from Children with Obesity Differs According to Prebiotic Choice and Bacterial Community Composition.
    Holmes ZC; Silverman JD; Dressman HK; Wei Z; Dallow EP; Armstrong SC; Seed PC; Rawls JF; David LA
    mBio; 2020 Aug; 11(4):. PubMed ID: 32788375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of prebiotic intake on gut microbiota, intestinal permeability and glycemic control in children with type 1 diabetes: study protocol for a randomized controlled trial.
    Ho J; Reimer RA; Doulla M; Huang C
    Trials; 2016 Jul; 17(1):347. PubMed ID: 27456494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Capacity of the Fecal Microbiota From Malawian Infants to Ferment Resistant Starch.
    Wang Y; Mortimer EK; Katundu KGH; Kalanga N; Leong LEX; Gopalsamy GL; Christophersen CT; Richard AC; Shivasami A; Abell GCJ; Young GP; Rogers GB
    Front Microbiol; 2019; 10():1459. PubMed ID: 31316490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of
    Groele L; Szajewska H; Szypowska A
    BMJ Open; 2017 Oct; 7(10):e017178. PubMed ID: 29025837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunistic bacteria confer the ability to ferment prebiotic starch in the adult cystic fibrosis gut.
    Wang Y; Leong LEX; Keating RL; Kanno T; Abell GCJ; Mobegi FM; Choo JM; Wesselingh SL; Mason AJ; Burr LD; Rogers GB
    Gut Microbes; 2019; 10(3):367-381. PubMed ID: 30359203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycation compounds - implications for human health.
    Hellwig M; Diel P; Eisenbrand G; Grune T; Guth S; Henle T; Humpf HU; Joost HG; Marko D; Raupbach J; Roth A; Vieths S; Mally A
    Crit Rev Toxicol; 2024 Sep; 54(8):485-617. PubMed ID: 39150724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between diet, the gut microbiome and short chain fatty acids in youth with islet autoimmunity and type 1 diabetes.
    Harbison JE; Thomson RL; Wentworth JM; Louise J; Roth-Schulze A; Battersby RJ; Ngui KM; Penno MAS; Colman PG; Craig ME; Barry SC; Tran CD; Makrides M; Harrison LC; Couper JJ
    Pediatr Diabetes; 2021 May; 22(3):425-433. PubMed ID: 33470492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does a high dietary intake of resistant starch affect glycaemic control and alter the gut microbiome in women with gestational diabetes? A randomised control trial protocol.
    Latino C; Gianatti EJ; Mehta S; Lo J; Devine A; Christophersen C
    BMC Pregnancy Childbirth; 2022 Jan; 22(1):46. PubMed ID: 35042457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Swapping White for High-Fibre Bread Increases Faecal Abundance of Short-Chain Fatty Acid-Producing Bacteria and Microbiome Diversity: A Randomized, Controlled, Decentralized Trial.
    Wang Y; Wymond B; Tandon H; Belobrajdic DP
    Nutrients; 2024 Mar; 16(7):. PubMed ID: 38613022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Butyrylated starch is less susceptible to enzymic hydrolysis and increases large-bowel butyrate more than high-amylose maize starch in the rat.
    Bajka BH; Topping DL; Cobiac L; Clarke JM
    Br J Nutr; 2006 Aug; 96(2):276-82. PubMed ID: 16923221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged Remission Induced by FENofibrate in children with newly diagnosed type 1 diabetes (PRIFEN): protocol of a randomised controlled trial.
    Groele L; Dżygało K; Kowalska A; Szypowska A
    BMJ Open; 2024 Feb; 14(2):e076882. PubMed ID: 38341215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
    Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
    Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.